Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial

letter

. 1996 Feb;72(1):71. doi: 10.1136/sti.72.1.71

Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial.

PMCID: PMC1195600 PMID: 8655177

These references are in PubMed. This may not be the complete list of references from this article.

Hohenleutner U., Landthaler M., Braun-Falco O. Postoperative adjuvante Therapie mit Interferon-Alfa-2b nach Laserchirurgie von Condylomata acuminata. Hautarzt. 1990 Oct;41(10):545–548. [PubMed] [Google Scholar]